Comparing Genome Scale Metabolic Models of the non-resistant Enterococcus faecalis ATCC 19433 and the multi-resistant Enterococcus faecalis V583.

Amino acid auxotrophies Energy demand Enterococcus faecalis Genome-scale metabolic model

Journal

Journal of biotechnology
ISSN: 1873-4863
Titre abrégé: J Biotechnol
Pays: Netherlands
ID NLM: 8411927

Informations de publication

Date de publication:
10 Jul 2024
Historique:
received: 21 11 2023
revised: 26 06 2024
accepted: 08 07 2024
medline: 13 7 2024
pubmed: 13 7 2024
entrez: 12 7 2024
Statut: aheadofprint

Résumé

Enterococcus faecalis is a versatile lactic acid bacterium with a large variety of implications for humans. While some strains of this species are pathobionts being resistant against most of the common antibiotics, other strains are regarded as biological protectants or even probiotics. Accordingly, E. faecalis strains largely differ in the size and content of their accessory genome. In this study, we describe the genome-scale metabolic network reconstruction of E. faecalis ATCC 19433, a non-resistant human-associated strain. A comparison of the genome-scale metabolic model (GSM) of E. faecalis ATCC 19433 with a previously published GSM of the multi-resistant pathobiontic E. faecalis V583 reveals high similarities in the central metabolic abilities of these two human associated strains. This is reflected, e.g., in the identical amino acid auxotrophies. The ATCC 19433 strain, however, has a 14.1% smaller genome than V583 and lacks the multiple antibiotic resistance genes and genes involved in capsule formation. Based on the measured metabolic fluxes at different growth rates, the energy demand at zero growth was calculated to be about 40% lower for the ATCC 19433 strain compared to V583. Furthermore, the ATCC 19433 strain seems less prone to the depletion of amino acids utilizable for energy metabolism. This might hint at a lower overall energy demand of the ATCC 19433 strain as compared to V583.

Identifiants

pubmed: 38996920
pii: S0168-1656(24)00192-5
doi: 10.1016/j.jbiotec.2024.07.006
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 The Author(s). Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Seyed Babak Loghmani (SB)

Ruprecht-Karls University Heidelberg, Bioquant, Center for Organismal Studies, Im Neuenheimer Feld 276, 69120 Heidelberg, Germany.

Eric Zitzow (E)

Rostock University Medical Centre, Institute of Medical Microbiology, Virology and Hygiene, Schillingallee 70, 18057 Rostock, Germany.

Luisa Schwarzmüller (L)

Ruprecht-Karls University Heidelberg, Bioquant, Center for Organismal Studies, Im Neuenheimer Feld 276, 69120 Heidelberg, Germany.

Yvonne Humboldt (Y)

Rostock University Medical Centre, Institute of Medical Microbiology, Virology and Hygiene, Schillingallee 70, 18057 Rostock, Germany.

Philip Eisenberg (P)

Rostock University Medical Centre, Institute of Medical Microbiology, Virology and Hygiene, Schillingallee 70, 18057 Rostock, Germany.

Bernd Kreikemeyer (B)

Rostock University Medical Centre, Institute of Medical Microbiology, Virology and Hygiene, Schillingallee 70, 18057 Rostock, Germany.

Nadine Veith (N)

Ruprecht-Karls University Heidelberg, Bioquant, Center for Organismal Studies, Im Neuenheimer Feld 276, 69120 Heidelberg, Germany.

Ursula Kummer (U)

Ruprecht-Karls University Heidelberg, Bioquant, Center for Organismal Studies, Im Neuenheimer Feld 276, 69120 Heidelberg, Germany.

Tomas Fiedler (T)

Rostock University Medical Centre, Institute of Medical Microbiology, Virology and Hygiene, Schillingallee 70, 18057 Rostock, Germany. Electronic address: tomas.fiedler@med.uni-rostock.de.

Classifications MeSH